Rationale for and Design of the CREATIVE-AF Trial: Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effect of Irbesartan on Oxidative Stress and Adhesion Molecules in Patients with Persistent Atrial Fibrillation

By Goette Andreas  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 565-572

Adis International

Access to resources Recommend Favorite

Angiotensin II receptor blockers in the prevention of atrial fibrillation

By Barra Silvia   Silvestri Nunzia   Vitagliano Giancarlo   Madrid Alfredo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1395-1411

Informa Healthcare

Access to resources Recommend Favorite

Renin-Angiotensin System Block and Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 12, Iss. 11, 2005-06 ,pp. : 1331-1337

Bentham Science Publishers

Access to resources Recommend Favorite

Antineoplastics: Paroxysmal atrial fibrillation in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1255, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Nifekalant boosts the efficacy of electrical defibrillation in patients with persistent and paroxysmal atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite